866-997-4948(US-Canada Toll Free)

Dental Partnering Terms and Agreements

Published By :

Current Partnering

Published Date : Jul 2013

Category :

Dental Devices

No. of Pages : 287 Pages


The Dental Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the dental partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter dental partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors dental technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partners negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered contract documents provide this insight where press releases do not.

This report contains over 500 links to online copies of actual dental deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partners flexibility on a wide range of important issues, many of which will have a significant impact on each partys ability to derive value from the deal.

The initial chapters of this report provide an orientation of dental dealmaking and business activities. 

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in dental dealmaking since 2007 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development.

Chapter 3 provides a review of the leading dental deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of dental deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 5 provides comprehensive access to all dental deals since 2007 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all dental partnering deals signed and announced since 2007. The chapter is organized by specific dental therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all dental partnering deals signed and announced since 2007. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in dental partnering and dealmaking since 2007.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of dental technologies and products.
Table of Content

Executive Summary

Chapter 1 Introduction

Chapter 2 Trends in dental dealmaking
2.1. Introduction
2.2. Dental partnering over the years
2.3. Bigpharma dental dealmaking activity
2.4. Bigpharma not active in dental
2.5. Dental partnering by deal type
2.6. Dental partnering by industry sector
2.7. Dental partnering by stage of development 
2.8. Dental partnering by technology type 
2.9. Dental partnering by dental indication 
2.10. Average deal terms for dental
2.10.1 Dental headline values
2.10.2 Dental upfront payments
2.10.3 Dental milestone payments
2.10.4 Dental royalty rates

Chapter 3 Leading dental deals
3.1. Introduction
3.2. Top dental deals by value
3.3. Top dental deals involving bigpharma

Chapter 4 Bigpharma dental deals
4.1. Introduction
4.2. How to use bigpharma partnering deals
4.3. Bigpharma dental partnering company profiles
Amgen
CSL 
Daiichi Sankyo 
Eisai 
GlaxoSmithKline 
Pfizer 
Sanofi 
Servier
Teva

Chapter 5 Dental partnering contracts directory
5.1. Introduction 
5.2. By deal type 
Asset purchase
Collaborative R&D 
Contract service 
Co-promotion 
Development 
Distribution 
Licensing 
Litigation 
Manufacturing 
Marketing 
Option
Settlement
Sub-license 
Supply 
Termination
5.3. By stage of development
Marketed 
Phase II 
Phase III 
Preclinical
5.4. By technology type
Biological compounds 
Biomarkers 
Biomaterials 
Devices 
Diagnostics 
Topical
Transmucosal 
Implant
Small molecules

Chapter 6 Dental dealmaking by indication
6.1. Introduction
6.2. Deals by therapeutic indication
Dental 
Dental caries 
Mouth ulcer 
Mucositis 
Oral health 
Periodontal disease 
Xerostomia

Chapter 7 Partnering resource center
7.1. Online partnering 
7.2. Partnering events 
7.3. Further reading on dealmaking

Appendices

Appendix 1 Directory of dental deals by company A-Z 2007-2013

Appendix 2 Directory of dental deals by deal type 2007-2013

Appendix 3 Directory of dental deals by stage of development 2007-2013

Appendix 4 Directory of dental deals by technology type 2007-2013

Appendix 5 Deal type definitions
About Wildwood Ventures 
Current Partnering 
Current Agreements 
Recent titles from CurrentPartnering 
Order Form Reports 
Order Form Therapy Reports

List of Chart


Figure 1: Dental partnering since 2007
Figure 2: Bigpharma top 50 dental deals 2007 to 2012
Figure 3: Bigpharma dental deal frequency 2007 to 2012
Figure 4: Inactive bigpharma in dental 2007-2013
Figure 5: Dental partnering by deal type since 2007
Figure 6: Dental partnering by industry sector since 2007
Figure 7: Dental partnering by stage of development since 2007
Figure 8: Dental partnering by technology type since 2007 
Figure 9: Dental partnering by dental target since 2007 
Figure 10: Dental deals with a headline value
Figure 11: Dental deal headline value distribution, US$million discovery stage
Figure 12: Dental deal headline value distribution, US$million preclinical stage
Figure 13: Dental deal headline value distribution, US$million phase I stage 
Figure 14: Dental deal headline value distribution, US$million phase II stage 
Figure 15: Dental deal headline value distribution, US$million phase III stage 
Figure 16: Dental deal headline value distribution, US$million regulatory stage
Figure 17: Dental deal headline value distribution, US$million marketed stage 
Figure 18: Summary median headline value by stage of development, 2007-2013 
Figure 19 Dental deals with upfront payment values
Figure 20: Dental deal upfront payment distribution, US$million discovery stage
Figure 21: Dental deal upfront payment distribution, US$million preclinical stage
Figure 22: Dental deal upfront payment distribution, US$million phase I stage
Figure 23: Dental deal upfront payment distribution, US$million phase II stage
Figure 24: Dental deal upfront payment distribution, US$million phase III stage 
Figure 25: Dental deal upfront payment distribution, US$million regulatory stage 
Figure 26: Dental deal upfront payment distribution, US$million marketed stage 
Figure 27: Summary median upfront payments by stage of development, 2007-2013 
Figure 28: Dental deals with milestone payments 
Figure 29: Dental deal milestone distribution, US$million discovery stage 
Figure 30: Dental deal milestone distribution, US$million preclinical stage 
Figure 31: Dental deal milestone distribution, US$million phase I stage 
Figure 32: Dental deal milestone distribution, US$million phase II stage 
Figure 33: Dental deal milestone distribution, US$million phase III stage 
Figure 34: Dental deal milestone distribution, US$million regulatory stage 
Figure 35: Dental deal milestone distribution, US$million marketed stage
Figure 36: Dental deals with royalty rates, % 
Figure 37: Dental deal royalty rate distribution, US$million discovery stage 
Figure 38: Dental deal royalty rate distribution, US$million preclinical stage
Figure 39: Dental deal royalty rate distribution, US$million phase I stage 
Figure 40: Dental deal royalty rate distribution, US$million phase II stage 
Figure 41: Dental deal royalty rate distribution, US$million phase III stage 
Figure 42: Dental deal royalty rate distribution, US$million regulatory stage 
Figure 44: Summary median royalty rate by stage of development, 2007-2013 
Figure 45: Top dental deals by value since 2007
Figure 46: Top dental deals signed by bigpharma value since 2007
Figure 47: Online partnering resources 
Figure 48: Forthcoming partnering events

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *